Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Skin Appendage Disorders
|
October 30, 2023
Racial and Ethnic Diversity in Janus Kinase Inhibitor Alopecia Areata Clinical Trials: A Systematic Review
Ogechi Ezemma, Shivali Devjani, Balaji Jothishankar, et al.
Drugs
|
May 11, 2023
Androgenetic Alopecia: Therapy Update
Shivali Devjani, Ogechi Ezemma, Kristen J Kelley, et al.
Journal of Drugs in Dermatology : JDD
|
December 13, 2021
Body Hair and Identity in Transgender Men: A Cross-Sectional Survey
James Pathoulas, Chloe Walker, Kelly Flanagan, et al.
Journal of Drugs in Dermatology : JDD
|
October 11, 2022
The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
Christine Pham, Calvin Sung, Margit Juhasz, et al.
The Journal of Investigative Dermatology
|
March 25, 2022
Predictors of QOL in Patients with Alopecia Areata
Maryanne Senna, Justin Ko, Marc Glashofer, et al.
Dermatology and Therapy
|
March 30, 2022
The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
Heather L Gelhorn, Katelyn Cutts, Emily Edson-Heredia, et al.
International Journal of Women'S Dermatology
|
April 12, 2024
Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
Ambika Nohria, Ya-Han Crystal Zhang, Deesha Desai, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 26, 2025
A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
Jonathan Mauer, Chiara Whichello, Brett Hauber, et al.
Journal of the American Academy of Dermatology
|
November 28, 2025
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, et al.
Advances in Therapy
|
July 22, 2021
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
Maryanne Senna, Justin Ko, Antonella Tosti, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Skin Appendage Disorders
|
October 30, 2023
Racial and Ethnic Diversity in Janus Kinase Inhibitor Alopecia Areata Clinical Trials: A Systematic Review
Ogechi Ezemma, Shivali Devjani, Balaji Jothishankar, et al.
Drugs
|
May 11, 2023
Androgenetic Alopecia: Therapy Update
Shivali Devjani, Ogechi Ezemma, Kristen J Kelley, et al.
Journal of Drugs in Dermatology : JDD
|
December 13, 2021
Body Hair and Identity in Transgender Men: A Cross-Sectional Survey
James Pathoulas, Chloe Walker, Kelly Flanagan, et al.
Journal of Drugs in Dermatology : JDD
|
October 11, 2022
The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
Christine Pham, Calvin Sung, Margit Juhasz, et al.
The Journal of Investigative Dermatology
|
March 25, 2022
Predictors of QOL in Patients with Alopecia Areata
Maryanne Senna, Justin Ko, Marc Glashofer, et al.
Dermatology and Therapy
|
March 30, 2022
The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
Heather L Gelhorn, Katelyn Cutts, Emily Edson-Heredia, et al.
International Journal of Women'S Dermatology
|
April 12, 2024
Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
Ambika Nohria, Ya-Han Crystal Zhang, Deesha Desai, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 26, 2025
A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
Jonathan Mauer, Chiara Whichello, Brett Hauber, et al.
Journal of the American Academy of Dermatology
|
November 28, 2025
Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
Maryanne Senna, Arash Mostaghimi, Rodney Sinclair, et al.
Advances in Therapy
|
July 22, 2021
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
Maryanne Senna, Justin Ko, Antonella Tosti, et al.
Page
of 2